Canadian companies are leading in femtech innovation. But where is the funding?
Canadian femtech companies are gaining traction, with startups like Coral and Aranexx addressing women's health issues such as menopause. Despite their innovation, funding for these companies remains limited, with women-led startups receiving only a small fraction of venture capital. The gap in women's health solutions presents both a societal and economic challenge, highlighting the need for increased investment in femtech.
- ▪Montreal startup Coral raised $4 million to support its virtual clinic for women navigating menopause.
- ▪The total capital for Coral has reached $8 million, allowing it to expand services across Canada.
- ▪Women-led startups in Canada receive only about 4% of venture capital funding, despite higher returns on investment compared to male-led startups.
The Globe and Mail publishes from Canada and files mainly under world. We currently carry 1,936 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Globe and Mail |
| Canonical URL | https://www.theglobeandmail.com/business/article-canadian-companies-are-leading-in-femtech-innovation-but-where-is-the/ |
| Publication time | Tue, 26 May 2026 11:00:00 +0000 |
| Retrieval time | 2026-05-26T11:07:48.493Z |
| Last seen | 2026-05-26T11:07:48.493Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | rSNSJoiaWA40 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Open this photo in gallery:Fiona Lake Waslander founded her company, Coral, to help women navigate menopause. “When that promotion comes up, you’re not anywhere on the thriving scale.”Galit Rodan/The Globe and MailShareSave for laterPlease log in to bookmark this story.Log InCreate Free AccountWhen Montreal startup Coral closed a $4-million financing round this spring, it was a win for Canada’s femtech ecosystem: Innovation in products that directly affect women’s health care needs.Coral is a virtual clinic for women navigating perimenopause, menopause and midlife health. Users can access coaching, testing and personalized treatment plans from medical professionals while tracking their progress in the app. Fiona Lake Waslander, Coral’s CEO and co-founder, launched the startup in 2024.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Globe and Mail.
Discussion
0 commentsMore from The Globe and Mail
